James Roach
James Roach is an experienced NHS director having held roles in hospitals, clinical commissioning groups and in joint roles with social care. James runs Conclusio Limited, developing innovative solutions in health and care systems in UK and China.
Latest articles
Pf Webinar: Adopting Agile in pharma for more effective cross-functional marketing teamwork
Pf is proud to announce the second instalment of the FREE webinar series with Triducive. This webinar focuses on Agile and how it can...
New Patient Recruitment Centres for late-phase clinical research
NHS patients will benefit from easier access to clinical research opportunities, following a £7m government investment to launch five new regional Patient Recruitment Centres...
NICE recommends new triple negative breast cancer treatment
Draft guidance published today by the National Institute for Health and Care Excellence (NICE) recommends Roche's Tecentriq®▼ (atezolizumab) for treating people with a type...
Popular articles
Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours
A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
NHS roadmap to safely bring back routine operations during COVID-19
Health leaders have set out a series of measures to help local hospitals plan to increase routine operations and treatment, while keeping the necessary...
Roche develops new COVID-19 antibody test
Roche has announced the development and upcoming launch of a new COVID-19 antibody test. Its Elecsys® Anti-SARS-CoV-2 serology test will detect antibodies in people...
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
BIVDA comments on Roche COVID-19 antibody test authorisation
The British In Vitro Diagnostics Association (BIVDA) has commented on the Roche COVID-19 antibody test authorisation by Public Health England. BIVDA is delighted to see...